Positive earnings surprises and optimistic future guidance are key drivers of stock price appreciation. Novavax's better-than-expected Q1 GAAP EPS results and the updated FY24 guidance indicate strong financial health and growth prospects, likely leading to increased investor confidence and demand for NVAX shares in the short term.